In December, Curtis said the show would be returning to HGTV in a newsletter announcement sent out to fans via email. HGTV ...

The quiet rise of electric cars is changing how people move. It is also changing how many people feel while moving. More ...

The University of Montana saw $149.9 million in research expenditures in Fiscal Year 2025, up from $143.8 million the ...

Their motion-sickness studies are just one part of UM’s robust research enterprise, which in fiscal year 2025 posted yet ...

Gulp down a motion sickness tablet because the whirlwind is set to continue next week. There's a spicy first Fed meeting of ...

With U.S. President ‍Donald Trump, Europe and NATO stepping back from their icy ​precipice over Greenland, markets - with the ...

Nausea, pale skin, cold sweats, fatigue, increased heart rate – the whole experience can feel debilitating, especially when it strikes at the worst possible moment. But whether you’re struggling with ...

Editorial Note: Talk Android may contain affiliate links on some articles. If you make a purchase through these links, we will earn a commission at no extra cost to you. Learn more. Raise your hand if ...

In clinical trials, the incidence of vomiting was significantly lower with tradipitant compared with placebo during boat trips. The Food and Drug Administration (FDA) has approved Nereus™ (tradipitant ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The cost of the approved drug ...

The U.S. FDA has approved its first pharma treatment in more than 40 years for motion sickness. The green light for Nereus (tradipitant), from Vanda Pharmaceuticals Inc., was based on three clinical ...

WASHINGTON, Dec. 30, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved NEREUS™ (tradipitant), an oral ...